Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
AOD-9604 offers a gentler approach with more selective fat targeting and fewer systemic effects, making it suitable for individuals who cannot tolerate GLP-1 agonists or prefer a more focused mechanism
Both are prohibited by WADA
Explore all available options in our [best weight loss injection 2026 guide](/guides/best-weight-loss-injection-2026-complete-guide) and our [complete injectable peptides guide](/guides/injectable-peptides-guide-types-benefits-safety)
Affibody announces termination of ABY-039 (FcRn) Program [press release]
US$ 24.14
US$ 22.98
US$ 29.60
US$ 20.95
US$ 26.89
